Authors:
ROSENBERG L
PALMER JR
SANDS MI
GRIMES D
BERGMAN U
DALING J
MILLS A
Citation: L. Rosenberg et al., MODERN ORAL-CONTRACEPTIVES AND CARDIOVASCULAR-DISEASE, American journal of obstetrics and gynecology, 177(3), 1997, pp. 707-715
Authors:
ROSENBERG L
BEGAUD B
BERGMAN U
BROWN B
BUIST AS
CRAMER D
DALING J
GRIMES D
KEMPER F
MILLS A
Citation: L. Rosenberg et al., WHAT ARE THE RISKS OF 3RD-GENERATION ORAL-CONTRACEPTIVES - ARE 3RD-GENERATION ORAL-CONTRACEPTIVES SAFE, Human reproduction, 11(4), 1996, pp. 687-688
Authors:
COOK L
WEISS N
SCHWARTZ S
WHITE E
MCKNIGHT B
MOORE D
DALING J
Citation: L. Cook et al., TAMOXIFEN THERAPY AND SUBSEQUENT OVARIAN, ENDOMETRIAL, AND BREAST-CANCER, American journal of epidemiology, 141(11), 1995, pp. 11-11
Citation: L. Bu et al., RISK OF BREAST-CANCER ASSOCIATED WITH INDUCED-ABORTION IN A POPULATION AT LOW-RISK OF BREAST-CANCER, American journal of epidemiology, 141(11), 1995, pp. 85-85
Authors:
CRITCHLOW C
DALING J
HOLMES K
KUYPERS J
SAYER J
HURT C
SURAWICZ C
HART P
DUNPHY C
GOLDBAUM G
KIVIAT N
Citation: C. Critchlow et al., DEVELOPMENT OF ANAL SQUAMOUS INTRAEPITHELIAL LESIONS AMONG HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-SEROPOSITIVE AND HIV-SERONEGATIVE HOMOSEXUAL MEN, American journal of epidemiology, 138(8), 1993, pp. 588-589